ArticleThe Journal of pathology2022

Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.

Sara Lahoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.